Uncertainty about future regulations clouds the future of agricultural biotechnology in the U.S.
New foods like a mushroom altered with CRISPR gene editing are falling outside the purview of regulators.
Yellow fever has already killed hundreds in two African countries, and health officials fear it could spread further.
Researchers used a brain-computer interface to give a man control over his paralyzed hand.
A Facebook billionaire makes a major investment in immunotherapy.
Clues to novel treatments could be gleaned from people who aren’t sick, but should be.
The attempt is another controversial test of whether gene-modified people are possible.
A genetic technology that can kill off mosquito species could eradicate malaria. But is it too risky to ever use?
A government investigation of Theranos’s lab has documented a host of troubles at the blood-testing startup.
The first gene therapy approved in the Western world costs $1 million and has been used just once. The doctor who tried it says the price is “absolutely too high.”